ABO Discrepancy Resolution: General Guidelines

How to Subscribe
MLS & MLT Comprehensive CE Package
Includes 181 CE courses, most popular
$109Add to cart
Pick Your Courses
Up to 8 CE hours
$55Add to cart
Individual course$25Add to cart
The page below is a sample from the LabCE course ABO Typing Discrepancies. Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.

Learn more about ABO Typing Discrepancies (online CE course)
ABO Discrepancy Resolution: General Guidelines

Unresolved ABO discrepancies can compromise patient safety. When encountered, it is critical to reach a resolution in order to report the correct patient ABO group.
Generally, the ABO group of the patient can be hypothesized from the patient data with varying degrees of certainty. Deriving a hypothesis about the ABO type is necessary so that you can determine the most appropriate problem-solving steps to follow for resolution.
The following guidelines may help with ABO discrepancy resolution:
  1. ABO reactions with reagent antisera and red cells are generally strong (3 – 4+); weak reactions should be noted.
  2. Mixed field reactions are not typically expected when performing ABO forward typing.
  3. Patient history and clinical data often provide hints regarding possible resolution. Useful patient history information includes previous ABO typing results, transfusion history (number of units and ABO type of units), transplantation history, and the volume of fluids administered prior to admission.
Table 13. Patient Results Demonstrating ABO Discrepancy.
Anti-AAnti-BA1 cellsB cells
Patient Results4+01+4+
In Table 13, the forward typing would indicate that the patient is a group A, demonstrating a strong reaction with anti-A. The reverse typing is consistent with group A except for the weak reaction seen with A1 cells. Given the strength of this reaction (1+), it is most likely not due to anti-A. The most probable type for this patient is group A. Your next step should be gathering data that will attempt to explain and optimally eliminate the unexpected reaction with A1 cells.